Cargando…
Effect of milrinone on cardiac functions in patients undergoing coronary artery bypass graft: a meta-analysis of randomized clinical trials
BACKGROUND AND AIM: Inotropes are commonly used to treat myocardial dysfunction, which is the major complication after coronary artery bypass graft (CABG). Milrinone, a phosphodiesterase 3 inhibitor, is one of these inotropes. Recently, a number of clinical studies have been carried out to evaluate...
Autores principales: | You, Zhigang, Huang, Lin, Cheng, Xiaoshu, Wu, Qinghua, Jiang, Xinghua, Wu, Yanqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4699515/ https://www.ncbi.nlm.nih.gov/pubmed/26766900 http://dx.doi.org/10.2147/DDDT.S77464 |
Ejemplares similares
-
The metabolic and renal effects of adrenaline and milrinone in patients with myocardial dysfunction after coronary artery bypass grafting
por: Heringlake, Matthias, et al.
Publicado: (2007) -
The Effect of Milrinone on the Right Ventriclular Function in Patients with Reduced Right Ventricular Function Undergoing Off-pump Coronary Artery Bypass Graft Surgery
por: Lee, Jong Hwa, et al.
Publicado: (2006) -
Effect of Intravenous Levosimendan or Milrinone on Left Atrial Pressure in Patients Undergoing Off-Pump Coronary Artery bypass Grafting—A Prospective Double-Blind, Randomized Controlled Trial
por: Mondal, Abhinandan, et al.
Publicado: (2023) -
The effect of milrinone infusion on right ventricular function during coronary anastomosis and early outcomes in patients undergoing off-pump coronary artery bypass surgery
por: Jo, Hyong Rae, et al.
Publicado: (2010) -
Mercaptoalbumin Is Associated with Graft Patency in Patients Undergoing Coronary Artery Bypass Grafting
por: Brioschi, Maura, et al.
Publicado: (2022)